Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2020
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma
Kathryn Lasseter, Amin H Nassar, Lana Hamieh, et al.
Research Square
|
August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration
Tanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
Urologic Oncology
|
November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Vivek Narayan, Michael Harrison, Heather Cheng, et al.
Oncogene
|
February 24, 2024
Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D Sepich-Poore, Daniel McDonald, Evguenia Kopylova, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
The Lancet. Oncology
|
October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
JCI Insight
|
March 9, 2026
Determinants of pancreatic tropism in metastatic renal cell carcinoma
Haitao Xu, Payal Kapur, Alana Christie, et al.
Nature Cancer
|
July 14, 2021
Accelerating precision medicine in metastatic prostate cancer
Joaquin Mateo, Rana McKay, Wassim Abida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 29, 2020
Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma
Kathryn Lasseter, Amin H Nassar, Lana Hamieh, et al.
Research Square
|
August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration
Tanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
Urologic Oncology
|
November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
Vivek Narayan, Michael Harrison, Heather Cheng, et al.
Oncogene
|
February 24, 2024
Robustness of cancer microbiome signals over a broad range of methodological variation
Gregory D Sepich-Poore, Daniel McDonald, Evguenia Kopylova, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, et al.
The Lancet. Oncology
|
October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
JCI Insight
|
March 9, 2026
Determinants of pancreatic tropism in metastatic renal cell carcinoma
Haitao Xu, Payal Kapur, Alana Christie, et al.
Nature Cancer
|
July 14, 2021
Accelerating precision medicine in metastatic prostate cancer
Joaquin Mateo, Rana McKay, Wassim Abida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
Page
of 4